IMPACT THEME: Education & Learning; Health, Wellbeing & Social Care
WHAT THEY DO: Reversing the decline in Braille literacy through the invention, production and distribution of the world's first multiline digital Braille e-reader
YEAR FOUNDED: 2011
INVESTMENT AMOUNT: £200,000
INVESTMENT SOURCE: Resonance Bristol SITR Fund
INVESTMENT PURPOSE: Working capital to finalise product testing and support early manufacturing and distribution of the Canute 360
DEAL STRUCTURE: 6 year unsecured loan from the Resonance Bristol SITR Fund - 3 years interest only (6% total cost p.a.), 3 years amortising loan (7% total cost p.a.). SITR eligible
They are supporting the blind community through technology with a radical new multiline digital Braille e-reader called the Canute 360. Existing Braille displays can only show one line of text of between 12 and 80 characters at a time. The Canute 360 can store thousands of Braille e-book files in its built-in memory and show them across 360 cells. Bristol Braille’s purpose is to help reverse the decline in Braille literacy, particularly by the invention, production and distribution of new technology, dramatically widening access to Braille around the world.
Ed Rogers, Managing Director at BBT, commented: “Everyone in the Bristol Braille team are hugely grateful to Resonance for backing Canute. This is a device designed with, by and for Braille readers the world over.
We look forward to seeing it being used to expand the range of opportunities available to Braille readers, and blind people generally, as a direct result of Resonance’s investment.”
Resonance Limited is a company registered in England and Wales no. 04418625
Resonance Impact Investment Limited, a subsidiary of Resonance Limited, is authorized and regulated by the Financial Conduct Authority (FCA). Firm number 588462.
Disclaimer: This website does not contain, constitute, nor does it form part of, an offer to sell or purchase or a solicitation of an offer to sell or purchase, any securities, investments or financial instruments referred to herein or to enter into any other transaction described herein. Resonance is not providing, and will not provide, any investment advice or recommendation (personal or otherwise) to you in relation to any securities, investments or financial instruments or transactions described herein. Whilst all reasonable care has been taken to ensure the accuracy of the information contained in this website, neither Resonance nor its officers accept any liability for its contents or for any errors or omissions.